Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Disruption of spermatogenic cell adhesion and male infertility in mice lacking TSLC1/IGSF4, an immunoglobulin superfamily cell adhesion molecule.

Yamada D, Yoshida M, Williams YN, Fukami T, Kikuchi S, Masuda M, Maruyama T, Ohta T, Nakae D, Maekawa A, Kitamura T, Murakami Y.

Mol Cell Biol. 2006 May;26(9):3610-24.

2.

Cell adhesion and prostate tumor-suppressor activity of TSLL2/IGSF4C, an immunoglobulin superfamily molecule homologous to TSLC1/IGSF4.

Williams YN, Masuda M, Sakurai-Yageta M, Maruyama T, Shibuya M, Murakami Y.

Oncogene. 2006 Mar 9;25(10):1446-53.

PMID:
16261159
3.

Tumor suppressor in lung cancer (TSLC)1 suppresses epithelial cell scattering and tubulogenesis.

Masuda M, Kikuchi S, Maruyama T, Sakurai-Yageta M, Williams YN, Ghosh HP, Murakami Y.

J Biol Chem. 2005 Dec 23;280(51):42164-71. Epub 2005 Oct 13.

4.

Promoter hypermethylation of the potential tumor suppressor DAL-1/4.1B gene in renal clear cell carcinoma.

Yamada D, Kikuchi S, Williams YN, Sakurai-Yageta M, Masuda M, Maruyama T, Tomita K, Gutmann DH, Kakizoe T, Kitamura T, Kanai Y, Murakami Y.

Int J Cancer. 2006 Feb 15;118(4):916-23.

5.

Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer.

Kikuchi S, Yamada D, Fukami T, Masuda M, Sakurai-Yageta M, Williams YN, Maruyama T, Asamura H, Matsuno Y, Onizuka M, Murakami Y.

Clin Cancer Res. 2005 Apr 15;11(8):2954-61.

6.

Isolation of the mouse Tsll1 and Tsll2 genes, orthologues of the human TSLC1-like genes 1 and 2 (TSLL1 and TSLL2).

Fukami T, Satoh H, Williams YN, Masuda M, Fukuhara H, Maruyama T, Yageta M, Kuramochi M, Takamoto S, Murakami Y.

Gene. 2003 Dec 24;323:11-8.

PMID:
14659875
7.

Suppression of fibroblast activity by an inhibitor of dipeptidyl peptidase IV: a possible therapeutic strategy for rheumatoid arthritis.

Williams YN, Sugita T, Nosaka Y, Kubota T.

Clin Exp Rheumatol. 2003 Sep-Oct;21(5):685. No abstract available.

PMID:
14611136
8.

Dipeptidyl peptidase IV on activated T cells as a target molecule for therapy of rheumatoid arthritis.

Williams YN, Baba H, Hayashi S, Ikai H, Sugita T, Tanaka S, Miyasaka N, Kubota T.

Clin Exp Immunol. 2003 Jan;131(1):68-74.

Supplemental Content

Loading ...
Support Center